Effects of teriparatide on serum calcium in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate

被引：0
|
作者：
R. A. Wermers
C. P. Recknor
F. Cosman
L. Xie
E. V. Glass
J. H. Krege
机构：
[1] Mayo Clinic,Division of Endocrinology and Metabolism
[2] United Osteoporosis Centers,Clinical Research Center
[3] Helen Hayes Hospital,Eli Lilly and Company
[4] Lilly Corporate Center,undefined
来源：
Osteoporosis International | 2008年 / 19卷
关键词：
Alendronate; Hypercalcemia; Postmenopausal osteoporosis; Raloxifene; Serum calcium; Teriparatide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1055 / 1065
页数：10
相关论文
共 50 条
  • [1] Effects of teriparatide on serum calcium in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate
    Wermers, R. A.
    Recknor, C. P.
    Cosman, F.
    Xie, L.
    Glass, E. V.
    Krege, J. H.
    OSTEOPOROSIS INTERNATIONAL, 2008, 19 (07) : 1055 - 1065
  • [2] Efficacy of adding teriparatide versus switching to teriparatide in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate
    Cosman, F.
    Wermers, R. A.
    Recknor, C.
    Mauck, K. F.
    Xie, L.
    Glass, E. V.
    Krege, J. H.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S127 - S127
  • [3] Efficacy of adding teriparatide versus switching to teriparatide in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate
    Cosman, F.
    Wermers, R. A.
    Recknor, C.
    Mauck, K. F.
    Xie, L.
    Glass, E. V.
    Krege, J. H.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S89 - S89
  • [4] Efficacy of adding teriparatide versus switching to teriparatide in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate
    Cosman, F.
    Wermers, R. A.
    Recknor, C.
    Mauck, K. F.
    Xie, L.
    Glass, E. V.
    Krege, J. H.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S59 - S60
  • [5] Hip and spine strength effects of adding versus switching to teriparatide in postmenopausal women with osteoporosis treated with prior alendronate or raloxifene
    Cosman, Felicia
    Keaveny, Tony M.
    Kopperdahl, David
    Wermers, Robert A.
    Wan, Xiaohai
    Krohn, Kelly D.
    Krege, John H.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (06) : 1328 - 1336
  • [6] Effects of Teriparatide, Alendronate, or Both in Women with Postmenopausal Osteoporosis
    Finkelstein, Joel S.
    Wyland, Jason J.
    Lee, Hang
    Neer, Robert M.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (04): : 1838 - 1845
  • [7] Teriparatide improves bone microarchitecture in postmenopausal women previously treated with alendronate
    Li, J.
    Burr, D. B.
    Stepan, J. J.
    Dobnig, H.
    Fahrleitner-Pammer, A.
    Sipos, A.
    Mullamey, T.
    Westmore, M.
    Sato, M.
    Pavo, I.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S28 - S28
  • [8] Comparison of alendronate and raloxifene in postmenopausal women with osteoporosis
    Sanad, Z.
    Ellakwa, H.
    Desouky, B.
    CLIMACTERIC, 2011, 14 (03) : 369 - 377
  • [9] Effects of Teriparatide in Postmenopausal Women with Osteoporosis on Prior Alendronate or Raloxifene: Differences between Stopping and Continuing the Antiresorptive Agent
    Cosman, Felicia
    Wermers, Robert A.
    Recknor, Christopher
    Mauck, Karen F.
    Xie, Li
    Glass, Emmett V.
    Krege, John H.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (10): : 3772 - 3780
  • [10] Teriparatide Reduces Bone Microdamage Accumulation in Postmenopausal Women Previously Treated With Alendronate
    Dobnig, Harald
    Stepan, Jan J.
    Burr, David B.
    Li, Jiliang
    Michalska, Dana
    Sipos, Adrien
    Petto, Helmut
    Fahrleitner-Pammer, Astrid
    Pavo, Imre
    JOURNAL OF BONE AND MINERAL RESEARCH, 2009, 24 (12) : 1998 - 2006
12345